E3LSI research: An essential element of biodefense

Biosecurity and Bioterrorism

Volumn 3, Issue 2, 2005, Pages 128-137

  Green, Shane K ^a  

^a AMERICAN MEDICAL ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGICAL WARFARE; CIVIL DEFENSE; DISASTER PLANNING; ECONOMICS; ETHICS; HUMAN; LEGAL ASPECT; ORGANIZATION AND MANAGEMENT; RESEARCH; UNITED STATES;

BIOTERRORISM; CIVIL DEFENSE; DISASTER PLANNING; HUMANS; RESEARCH; UNITED STATES;

EID: 24644444315     PISSN: 15387135     EISSN: None     Source Type: Journal    
DOI: 10.1089/bsp.2005.3.128     Document Type: Article

References (60)

1. 3LS). Genome Canada. Available at: http://www. genomecanada.ca/GCethique/aPropos/index.asp?l=e Accessed August 31, 2004.
2. Convention on the Prohibition of the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on Their Destruction (1972). Available at: http://www.opbw.org. Accessed April 1, 2005.
3. Graham T. Biological weapons and international law. Science 2002;295:2325.
4. Rath J. Biological weapons, war crimes, and WWI. Science 2002;296:1235-1236.
5. The White House. Ask the White House - May 19, 2004. Available at: http://www.whitehouse.gov/ask/print/20040519. html. Accessed May 21, 2004.
6. st Century. Available at: http://www.whitehouse.gov/ homeland/20040430, html. Accessed May 1, 2004.
7. Schuler A. Billions for biodefense: federal agency biodefense funding, FY2001-FY2005. Biosecur Bioterror 2004;2(2):86-96.
8. DeFrancesco L. Throwing money at biodefense. Nat Biotechnol 2004;22(4):375-378.
9. Project BioShield Act of 2004. Available at: http:// frwebgate.access. gpo.gov/cgi-bin/getdoc.cgi?dbname=108_ cong_bills&docid=f:s15enr.txt.pdf. Accessed August 23, 2004.
10. Enserink M. New biodefense splurge creates hotbeds, shatters dreams. Science 2003;302:206-207.
11. Malakoff D. U.S. biodefense boom: eight new study centers. Science 2003;301:1450-1451.
12. Hirschberg R, LaMontagne J, Fauci AS. Biomedical research-an integral component of national security. N Engl J Med 2004;350(21):2119-2123.
13. Leitenberg M, Leonard J, Spertzel R. Biodefense crossing the line. Politics Life Sciences 2004;22(2):1-2.
14. Korch G. Leading edge of biodefense: the National Biodefense Analysis and Countermeasures Center. Available at: http://www.cbwtransparency.org/archive/ nbacc.pdf. Accessed August 1, 2004.
15. Butler D. Bioweapons treaty in disarray as U.S. blocks plans for verification. Nature 2001;414:675.
16. National Science Advisory Board for Biosecurity (NS-ABB). Available at: http://www.biosecurityboard.gov. Accessed April 6, 2005.
17. NSABB. FAQ #10. Available at: http://www.biosecurityboard.gov/faq.htm Accessed August 23, 2004.
18. Sidel V, Levy B. Terrorism "preparedness": diversion of resources and erosion of trust. Virtual Mentor 2004;6(5). Available at: http://www.ama-assn.org/ama/pub/category/ 12274.html. Accessed May 3, 2004.
19. Cohen HW, Gould RM, Sidel VW. The pitfalls of bioterrorism preparedness: the anthrax and smallpox experiences. Am J Public Health 2004;94:1667-1671.
20. Amadio JB. Bioterrorism preparedness funds well used at the local level. Am J Public Health 2005;95(3):373-374.
21. Altman S, Bassler BL, Beckwith J, et al. An open letter to Elias Zerhouni. Science 2005;307:1409-1410.
22. Check E. Protest letter accuses health agency of biodefence bias. Nature 2005;434:7.
23. Luongo KN, Averre D, Della Ratta R, Martellini M. Building a forward line of defense securing former Soviet biological weapons. Arms Control Today July/August 2004. Available at: http://www.armscontrol.org/act/2004_07-08/ Luongo.asp. Accessed April 8, 2005.
24. Fredrickson DS. The Recombinant DNA Controversy: A Memoir. Science, Policy and the Public Interest 1974-1981. Washington, DC: ASM Press; 2001.
25. Ember LR. The biodefense enterprise. Chem Eng News 2005;83(7):25-28.
26. Center for Law and the Public's Health at Georgetown and Johns Hopkins Universities. The Model State Emergency Health Powers Act. Available at: http://www.publichealthlaw. net/ MSEHPA/MSEHPA2.pdf. Accessed May 2, 2004.
27. Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (USA PATRIOT) Act of 2001. Available at: http:// frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname= 107_ cong_public_laws&docid=f:pub1056.107.pdf. Accessed August 23, 2004.
28. Annas GJ. Bioterrorism and public health law. JAMA 2002;288:2685-2686.
29. National Legal Aid & Defender Association. Significant provisions of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act (USA PATRIOT Act), P.L. 107-56, signed October 26, 2001. Available at: http://www. nlada.org/DMS/Documents/1006186143. 01/USA%20 Patriot%20Act%20Summary.pdf. Accessed August 27, 2004.
30. Crabtree P. Senate OKs "BioShield" bill for anti-terror drugs. San Diego Union-Tribune May 20, 2004;C1.
31. Shaffer D, Armstrong G, Higgins K, et al. Increased U.S. prescription trends associated with the CDC Bacillus anthracis antimicrobial postexposure prophylaxis campaign. Pharmacoepidemiol Drug Saf 1993;12(3):177-182.
32. Food and Drug Administration, U.S. Department of Health and Human Services. New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Federal Register 2002:67(105). Available at: http://www.fda.gov/OHRMS/ DOCKETS/98fr/053102a. pdf Accessed January 13, 2005.
33. DeNavas-Walt C, Proctor BD, Mills RJ. U.S. Census Bureau, Current Population Reports, P60-226, Income, Poverty, and Health Insurance Coverage in the United States: 2003. Washington, DC: U.S. Government Printing Office; 2004.
34. Institute of Medicine. Coverage Matters: Insurance and Health Care. Washington, DC: National Academy Press; 2001.
35. Wynia MK, Gostin LO. Ethical challenges in preparing for bioterrorism: barriers within the health care system. Am J Public Health 2004;94(7):1096-1102.
36. Schlosberg C, Wiley W. The impact of INS public charge determinations on immigrant access to health care. National Health Law Program (5/12/98). Available at: http://www.healthlaw.org/pubs/19980522publiccharge. html. Accessed March 2, 2004.
37. Landers SJ. Immigrants swell ranks of uninsured. American Medical News August 21, 2000. Available at: http://www.ama-assn.org/amednews/2000/08/21/ gvsa0821.htm. Accessed March 3, 2004.
38. Green SK. Bioterrorism and health care reform: no preparedness without access. Virtual Mentor 2004;6(5). Available at: http://www.ama-assn.org/ama/pub/ category/ 12275.html. Accessed August 30, 2004.
39. Southeast Regional Center of Excellence for Emerging Infections and Biodefense (SERCEB). Available at: https://www.serceb.org/researchers/cores/ core_i/index.html. Accessed August 27, 2004.
40. Cook-Deegan R. Policy, Ethics, and Law Core. Available at: http://rce.swmed.edu/comm/PEL%20abstract%20Apr04%2 0DC%20ann%20mtg.pdf. Accessed August 27, 2004.
41. Check E. U.S. army attacked over published patent for "bioweapons grenade." Nature 2003;423(6942):789.
42. Hambling D. Bunker-busters set to go nuclear. New Scientist November 17, 2002. Available at: http://www. newscientist.com/news/print.jsp?id=ns99993016. Accessed May 17, 2004.
43. National Science Foundation. Available at: http://www.nsf. gov/about/history. Accessed May 9, 2005.
44. Bush V. Science: The Endless Frontier. A Report to the President by Vannevar Bush. Director of the Office of Scientific Research and Development, July 1945. Washington DC: U.S. Government Printing Office; 1945. Available at: http://www.nsf.gov/od/lpa/nsf50/vbush1945.htm. Accessed May 25, 2004.
45. Steelman JR. Science and Public Policv: A Program for the Nation.
46. Quoted in: Guston DH, Woodhouse EJ, Sarewitz D. A science and technology focus for the Bush administration. Issues in Science and Technology Spring 2001. Richardson, TX: University of Texas at Dallas; 2001.
47. National Science Foundation Directorate for Social, Behavioral and Economic Sciences. Science Nuggets. Available at: http://www.nsf.gOv//sbe/ nuggets/911list/nugget.htm. Accessed May 25, 2004.
48. National Science Foundation, Directorate for Social, Behavioral and Economic Sciences. Available at: http://www. nsf.gov/sbe/. Accessed May 25, 2004.
49. Human Genome Project Budget. Available at: http://www. ornl.gov/sci/techresources/Human_Genome/project/budget.shtml. Accessed August 26, 2004.
50. Executive Order 13145 to Prohibit Discrimination in Federal Employment Based on Genetic Information. Available at: http://www.genome.gov/10002084. Accessed August 26, 2004.
51. National Human Genome Research Institute. Genetic Discrimination in Health Insurance or Employment. Available at: http://www.genome.gov/11510227. Accessed August 27, 2004.
52. Office of Legislative Policy and Analysis. S.306-The Genetic Information Nondiscrimination Act of 2005. Available at: http://olpa.od.nih.gov/tracking/ 109/senate_ bills/session1/S-306.asp. Accessed May 9, 2005.
53. Meslin EM, Thomson EJ, Boyer JT. Bioethics inside the beltway-the Ethical, Legal, and Social Implications Research Program at the National Human Genome Research Institute. Kennedy Inst Ethics 1997;7(3):291-298.
54. Green SK. The genomic era: what must public health do? Virtual Mentor 2003;5(11). Available at: http://www. ama-assn.org/ama/pub/category/11559.html. Accessed November 15, 2003.
55. Bohan S. Genome monitoring underfunded; program aims to prevent social discord from genetics findings. Alameda Times-Star April 13, 2003.
56. NIH-DOE Committee to Evaluate the Ethical, Legal, and Social Implications Program of the Human Genome Project. Report of the Joint NIH/DOE Committee to Evaluate the Ethical, Legal, and Social Implications Program of the Human Genome Project 1996. Available at: http://www.genome.gov/10001745. Accessed August 27, 2004.
57. Office of Biotechnology Activities, National Institutes of Health. About SACGT. Available at: http://www4. od.nih.gov/oba/sacgt/aboutsacgt.htm. Accessed December 3, 2004.
58. US Department of Health and Human Services. Establishment of the Secretary's Advisory Committee on Genetics, Health, and Society. Federal Register 2002;67(205). Available at: http://www4.od.nih.gov/oba/sacghs/SACGHSFR Noticeoct2302.pdf. Accessed December 3, 2004.
59. See, for example: Guston DH, Woodhouse EJ, Sarewitz D. A science and technology policy focus for the Bush administration. Issues in Science and Technology, Spring 2001. Richardson, TX: University of Texas at Dallas; 2001. Available at: http://www.aaas.org/spp/yearbook/2002/ch4.pdf. Accessed December 2, 2004.
60. 21st Century Nanotechnology Research and Development Act. Available at: http://frwebgate.access.gpo.gov/cgi-bin/ getdoc.cgi?dbname= 108_cong_bills&docid=f:s189enr.txt. pdf. Accessed August 26, 2004.